These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6804844)

  • 21. Design and analysis of non-inferiority mortality trials in oncology.
    Carroll K; Milsted B; Lewis JA
    Stat Med; 2004 Sep; 23(17):2771-4; author reply 2774-8. PubMed ID: 15316946
    [No Abstract]   [Full Text] [Related]  

  • 22. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research design strategies to evaluate the impact of formulations on abuse liability.
    McColl S; Sellers EM
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S52-62. PubMed ID: 16554125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR in oncology drug development.
    Galbraith SM
    NMR Biomed; 2006 Oct; 19(6):681-9. PubMed ID: 16986117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug development in paediatric oncology].
    Benninger-Döring G; Boos J
    Klin Padiatr; 2006; 218(3):152-6. PubMed ID: 16688671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ophthalmic drug development: procedural considerations.
    Novack GD
    J Glaucoma; 1998 Jun; 7(3):202-9. PubMed ID: 9627860
    [No Abstract]   [Full Text] [Related]  

  • 28. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical approaches to the discovery of new drugs.
    Suckling CJ
    Sci Prog; 1991; 75(298 Pt 3-4):323-59. PubMed ID: 1842854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulation, new techniques.
    Leuenberger H
    Pharm Acta Helv; 1982; 57(3):72-82. PubMed ID: 7071070
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tablet identification using near-infrared spectroscopy (NIRS) for pharmaceutical quality control.
    Alvarenga L; Ferreira D; Altekruse D; Menezes JC; Lochmann D
    J Pharm Biomed Anal; 2008 Sep; 48(1):62-9. PubMed ID: 18572342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compliance Policy Guide on Chapter 4 Human Drugs: Section 460.200 Pharmacy Compounding.
    J Pain Palliat Care Pharmacother; 2003; 17(1):99-106. PubMed ID: 14640347
    [No Abstract]   [Full Text] [Related]  

  • 34. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.
    Cone EJ
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S31-9. PubMed ID: 16458455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Requirements in clinical evaluation of drugs in oncology. Guidelines of the phase I/II study group of the Professional Society of Internal Oncology of the German Cancer Society].
    Queisser W; Hermann R; Edler L; Boerner D; Hinke A; Kaplan A; Pechan R; Peukert M; Rieder H; Sterz R
    Onkologie; 1990 Aug; 13(4):322-4. PubMed ID: 2234786
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful gastrointestinal cancer drug development.
    Hecht JR
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S24-7. PubMed ID: 17178281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of ordered mesoporous silica for the storage of drugs: the example of a pentapeptide encapsulated in a MSU-tween 80.
    Tourné-Péteilh C; Lerner DA; Charnay C; Nicole L; Bégu S; Devoisselle JM
    Chemphyschem; 2003 Mar; 4(3):281-6. PubMed ID: 12674601
    [No Abstract]   [Full Text] [Related]  

  • 39. The menace of substandard drugs.
    Roy J
    World Health Forum; 1994; 15(4):406-7. PubMed ID: 7999239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent applications of Chemical Imaging to pharmaceutical process monitoring and quality control.
    Gowen AA; O'Donnell CP; Cullen PJ; Bell SE
    Eur J Pharm Biopharm; 2008 May; 69(1):10-22. PubMed ID: 18164926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.